Innovative Cellular Therapeutics Holdings Ltd insider trades
Innovative Cellular Therapeutics Holdings Ltd has filed 6 Form 4s with the SEC that we hold, all for Lyell Immunopharma, Inc. (LYEL), as 10% owner. Across all of them we count 0 purchases worth $0 and 2 sales worth $274 reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($274). The largest single trade was a sale of 10 shares of Lyell Immunopharma, Inc. worth $137, dated 2026-07-16. The first filing on our record is dated 2026-06-18 and the latest 2026-07-27.
Lyell Immunopharma, Inc. (LYEL)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-07-16 | S, sale reported on Form 4 | 10 | $137 | 2026-07-17 |
| 2026-07-17 | S, sale reported on Form 4 | 10 | $137 | 2026-07-20 |
Counted from the Form 4 filings this reporting owner (SEC CIK 2095697) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms